Management of Oral Iron-Refractory Iron Deficiency Anemia in Pregnancy

Initial Evaluation and Treatment

For a pregnant patient with iron deficiency anemia not responding to oral iron therapy after 4 weeks, the next step is to switch to intravenous iron therapy, which is more effective and rapidly corrects both anemia and iron stores, as recommended by the Centers for Disease Control and Prevention (CDC) 1, 2
Verify compliance with oral iron supplementation and absence of acute illness, as these are prerequisites for determining true oral iron failure, according to the CDC 1, 2
Perform additional laboratory testing including mean corpuscular volume (MCV), red cell distribution width (RDW), and repeat ferritin to further characterize the anemia, as suggested by the CDC 1
Consider alternative diagnoses in women of African, Mediterranean, or Southeast Asian ancestry, where thalassemia minor or sickle cell trait may present as mild anemia unresponsive to oral iron, as recommended by the CDC 1
Assess hemoglobin severity: If hemoglobin is <9.0 g/dL, refer to a physician familiar with anemia during pregnancy for further medical evaluation, according to the CDC 1

Intravenous iron is indicated for pregnant patients who fail oral iron therapy, are intolerant to oral preparations, or require rapid correction of anemia, as recommended by the American College of Obstetricians and Gynecologists (ACOG) 1
Ferric carboxymaltose (Injectafer) is the preferred agent based on clinical trial evidence in pregnancy and postpartum populations, with a dosing regimen of 15 mg/kg body weight up to maximum 750 mg per dose, administered on two occasions separated by at least 7 days, for cumulative dose up to 1,500 mg, as recommended by the National Institute for Health and Care Excellence (NICE) 3
Administration time for ferric carboxymaltose is a 15-minute infusion, which is significantly more convenient than older preparations, as reported in the journal Gut 3
Alternative preparations include iron sucrose (Venofer) with a maximum dose of 200 mg per dose and a 10-minute infusion, and iron dextran (Cosmofer) which can give total dose in single 6-hour infusion but carries a 0.6-0.7% risk of serious reactions including anaphylaxis, as reported in the journal Gut 3

Reassess hemoglobin and ferritin at appropriate intervals to confirm response, as recommended by the CDC 1, 2
Expected response: Hemoglobin should increase by ≥1 g/dL within 2-4 weeks, according to the CDC 1
Once hemoglobin normalizes for gestational age, decrease to maintenance dose of 30 mg/day oral iron, as recommended by the CDC 1